Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion type Assertion NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_head.
- NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion wasGeneratedBy ECO_0000203 NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_provenance.
- NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion wasDerivedFrom befree-20150227 NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_provenance.
- NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion SIO_000772 19710697 NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_provenance.
- NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion evidence source_evidence_literature NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_provenance.
- NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_assertion description "[In this study, we analyzed gene expression modifications in CLL B cells after treatment with valproic acid (VPA), a well-tolerated anti-epileptic drug with HDAC inhibitory activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829542.RA1ezxaRGaPhXoopSpxDYOJhMfq_Y3DWCx3hf1tz3kjQY130_provenance.